Showing results (1591-1600 of 6,720) with videos related to
Sort By:
Pageof 672
Annals of Hematology|July 1, 2026
Early versus standard anti-thymocyte globulin administration in haploidentical transplantation using post-transplant cyclophosphamide: a pilot comparative studyGhazaleh Kheiri, Negar Nejati, Kobra Bagheri Valami, et al.Annals of Hematology|June 19, 2026
β2-microglobulin is superior to lactate dehydrogenase and bulky disease for risk stratification in diffuse large B-cell lymphoma patients with IPI 1-2Hung Chang, Yu-Shin Hung, Ming-Chung Kuo, et al.Annals of Hematology|June 18, 2026
Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic reviewMagdalena Benda, Patrick Reimann, Wolfgang Willenbacher, et al.Annals of Hematology|July 6, 2026
Lactate dehydrogenase (LDH) as a predictor of left atrial remodeling in patients with sickle cell anemiaFábio Galvão, Felipe Soares Maia, Mabel Rodrigues Rios, et al.Annals of Hematology|July 3, 2026
Real-world treatment patterns and outcomes in chronic lymphocytic leukemia: a multicenter retrospective study in GreeceEpameinondas Koumpis, Eva Minga, Persefoni Talimtzi, et al.Annals of Hematology|June 27, 2026
Allogeneic hematopoietic stem cell transplantation for a pediatric case of myelodysplastic syndrome with germline DDX41 mutationTiantian Hu, Wenli Zhang, Teng Zhang, et al.Annals of Hematology|July 31, 2021
Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndromeXue-Min Gao, Yan-Ying Yu, Hao Zhao, et al.Annals of Hematology|July 8, 2026
Baseline immunonutritional status drives CAR T-cell efficacy, survival, and safety in R/R lymphoma: validation of a pre-lymphodepletion PNI thresholdNa Zhang, Fan Yang, Rui Liu, et al.Annals of Hematology|March 23, 2026
FTO-CHRM3 axis regulates multiple myeloma progression: a machine learning-based identificationBo Lu, Ting Bin, Xue-Fei Deng, et al.Annals of Hematology|May 8, 2026
WT1 mRNA in peripheral blood enables early prognostic stratification in AML patients receiving venetoclax and azacitidine therapyHiroyuki Sugiura, Noboru Asada, Takeru Asano, et al.Pageof 672